(Q43851131)

27 November 2017

title

[(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers (English)

1 reference

27 November 2017

1 reference

1

Hayden T Ravert

1 reference

27 November 2017

5

Robert F Dannals

1 reference

27 November 2017

Ursula Scheffel

2

1 reference

27 November 2017

William B Mathews

series ordinal

3

1 reference

27 November 2017

John L Musachio

series ordinal

4

1 reference

27 November 2017

publication date

1 January 2002

1 reference

Nuclear Medicine and Biology

27 November 2017

published in

1 reference

27 November 2017

volume

29

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

47-53

1 reference

Synthesis and in vitro characterization of fluorinated U-50488 analogs for PET studies of kappa opioid receptors

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

Opiate receptor avidity and cerebral blood flow in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

Imaging opiate receptors in the human brain by positron tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

A series of novel, highly potent and selective agonists for the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

Autoradiography of [3H]U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

[11C]-methyl 4-[(3,4-dichlorophenyl)acetyl]-3-[(1-pyrrolidinyl)-methyl]-1- piperazinecarboxylate ([11C]GR89696): synthesis and in vivo binding to kappa opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

Quantification of Human Opiate Receptor Concentration and Affinity Using High and Low Specific Activity [11C]Diprenorphine and Positron Emission Tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

The kappa-opioid receptor: evidence for the different subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8051%2801%2900285-2

7 January 2021

10.1016/S0969-8051(01)00285-2

Identifiers

DOI

1 reference

27 November 2017

1 reference